Structures by: Asiri A. M.
Total: 216
(<i>Z</i>)-Ethyl 2-chloro-2-[2-(4-methylphenyl)hydrazono]acetate
C11H13ClN2O2
Acta Crystallographica Section E (2012) 68, 12 o3420
a=4.61520(10)Å b=9.94440(10)Å c=26.3152(3)Å
α=90.00° β=90.6920(10)° γ=90.00°
<i>cis</i>-Dichloridobis(<i>N</i>,<i>N</i>,<i>N</i>',<i>N</i>'-tetramethylethane-1,2-diamine)platinum(II)
C6H16Cl2N2Pt
Acta Crystallographica Section E (2012) 68, 12 m1562
a=11.8893(2)Å b=6.02070(10)Å c=15.8036(3)Å
α=90.00° β=110.549(2)° γ=90.00°
2-(Naphthalene-2-sulfonamido)-3-phenylpropanoic acid
C19H17NO4S
Acta Crystallographica Section E (2013) 69, 2 o194
a=8.0694(2)Å b=15.2168(4)Å c=14.0996(3)Å
α=90.00° β=92.505(2)° γ=90.00°
2-[(2-Hydroxynaphthalen-1-yl)methylideneamino]-5,6,7,8-tetrahydro-4<i>H</i>-cyclohepta[<i>b</i>]thiophene-3-carbonitrile
C21H18N2OS
Acta Crystallographica Section E (2013) 69, 2 o193
a=13.5472(2)Å b=14.4747(4)Å c=35.7902(6)Å
α=90.00° β=90.00° γ=90.00°
5-Acetyl-3-(5-phenyl-1<i>H</i>-pyrazol-3-yl)-1,3,4-thiadiazol-2(3<i>H</i>)-one monohydrate
C13H10N4O2S,H2O1
Acta Crystallographica Section E (2013) 69, 5 o798
a=7.6084(2)Å b=25.5788(4)Å c=7.6524(2)Å
α=90.00° β=111.974(3)° γ=90.00°
2-Chloro-6-(2,3-dichlorobenzenesulfonamido)benzoic acid
C13H8Cl3NO4S
Acta Crystallographica Section E (2013) 69, 6 o832
a=9.0164(3)Å b=18.6017(5)Å c=9.8574(3)Å
α=90.00° β=111.653(3)° γ=90.00°
1-Benzoyl-3-(4-fluorophenyl)thiourea
C14H11FN2OS
Acta Crystallographica Section E (2014) 70, 9 o1023-o1024
a=9.6265(4)Å b=11.1329(4)Å c=13.8252(5)Å
α=110.646(3)° β=100.708(3)° γ=102.762(3)°
3-Hydroxy-2-(toluene-4-sulfonylamino)-propionic acid
C10H13NO5S
Crystal Growth & Design (2014) 14, 4 1938
a=4.9709(2)Å b=9.7703(5)Å c=24.2865(13)Å
α=90.00° β=90.00° γ=90.00°
C50H36N2O10Zn2,C6H14N2O2,O2
C50H36N2O10Zn2,C6H14N2O2,O2
Crystal Growth & Design (2014) 14, 5 2522
a=17.053(6)Å b=11.363(4)Å c=18.518(6)Å
α=90.00° β=116.226(4)° γ=90.00°
C23H18N4O3
C23H18N4O3
The Journal of organic chemistry (2014) 79, 21 10593
a=5.87321(10)Å b=16.3775(3)Å c=19.4994(3)Å
α=90.00° β=96.9849(16)° γ=90.00°
C21H19N3O3
C21H19N3O3
The Journal of organic chemistry (2014) 79, 21 10593
a=7.8812(3)Å b=9.8170(3)Å c=11.9498(4)Å
α=95.127(3)° β=105.452(3)° γ=99.544(3)°
C23H19N3O
C23H19N3O
The Journal of organic chemistry (2014) 79, 21 10593
a=8.2888(4)Å b=10.3643(5)Å c=10.9122(6)Å
α=91.612(4)° β=100.785(4)° γ=102.962(4)°
2-(1,3-Benzothiazol-2-yliminomethyl)-2-naphthol
C18H12N2OS
Acta Crystallographica Section E (2009) 65, 4 o759
a=9.6398(2)Å b=14.9687(4)Å c=9.6646(2)Å
α=90.00° β=101.323(2)° γ=90.00°
3,5-Dimethyl-1-(4-sulfamidophenyl)-7-oxothiazol[4,5-d]pyradazine
C13H12N4O3S2
Acta Crystallographica Section E (2011) 67, 7 o1665
a=12.6048(10)Å b=13.2273(10)Å c=8.9703(7)Å
α=90.00° β=102.2420(10)° γ=90.00°
2,7-Dimethyl-1,3-thiazolo[4,5-<i>d</i>]pyridazin-4(5<i>H</i>)-one
C7H7N3OS
Acta Crystallographica Section E (2011) 67, 9 o2467
a=6.9262(4)Å b=7.0540(4)Å c=8.8079(6)Å
α=71.002(6)° β=75.845(5)° γ=85.570(5)°
(2<i>E</i>)-2-(Furan-2-ylmethylidene)-2,3-dihydro-1<i>H</i>-inden-1-one
C14H10O2
Acta Crystallographica Section E (2012) 68, 4 o1065
a=5.9333(8)Å b=7.6605(6)Å c=22.386(3)Å
α=90.00° β=91.582(14)° γ=90.00°